Regulation of TAK1/TAB1-Mediated IL-1β Signaling by Cytoplasmic PPARβ/δ

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Stockert, Josefine ^a   Wolf, Alexander ^b   Kaddatz, Kerstin ^a   Schnitzer, Evelyn ^a   Finkernagel, Florian ^a   Meissner, Wolfgang ^a   Müller Brüsselbach, Sabine ^a   Kracht, Michael ^b   Müller, Rolf ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 27; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; MAP KINASE KINASE KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; PROTEIN BINDING; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TAB1 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; CYTOPLASM; GENE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; MOUSE; NONHUMAN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA GENE; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSCRIPTION REGULATION; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HELA CELL LINE; METABOLISM; PROTEIN DOMAIN; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CYTOPLASM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HELA CELLS; HSP27 HEAT-SHOCK PROTEINS; HUMANS; INTERLEUKIN-1BETA; MAP KINASE KINASE KINASES; PPAR DELTA; PPAR-BETA; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION, GENETIC;

EID: 84876964236     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063011     Document Type: Article

References (65)

1. Desvergne B, Michalik L, Wahli W, (2006) Transcriptional regulation of metabolism. Physiol Rev 86: 465-514.
2. Peters JM, Shah YM, Gonzalez FJ, (2012) The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention. Nat Rev Cancer 12: 181-195.
3. Adhikary T, Kaddatz K, Finkernagel F, Schönbauer A, Meissner W, et al. (2011) Genomewide analyses define different modes of transcriptional regulation by peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta). PLoS One 6: e16344.
4. Lim H, Dey SK, (2002) A novel pathway of prostacyclin signaling-hanging out with nuclear receptors. Endocrinology 143: 3207-3210.
5. Tan NS, Michalik L, Di-Poi N, Ng CY, Mermod N, et al. (2004) Essential role of Smad3 in the inhibition of inflammation-induced PPARbeta/delta expression. Embo J 23: 4211-4221.
6. Odegaard JI, Ricardo-Gonzalez RR, Red Eagle A, Vats D, Morel CR, et al. (2008) Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance. Cell Metab 7: 496-507.
7. Kang K, Reilly SM, Karabacak V, Gangl MR, Fitzgerald K, et al. (2008) Adipocyte-derived Th2 cytokines and myeloid PPARdelta regulate macrophage polarization and insulin sensitivity. Cell Metab 7: 485-495.
8. Naruhn S, Meissner W, Adhikary T, Kaddatz K, Klein T, et al. (2010) 15-hydroxyeicosatetraenoic acid is a preferential peroxisome proliferator-activated receptor β/δ agonist. Mol Pharmacol 77: 171-184.
9. Stockert J, Adhikary T, Kaddatz K, Finkernagel F, Meissner W, et al. (2011) Reverse crosstalk of TGFβ and PPARβ/δ signaling identified by transcriptional profiling. Nucleic Acids Res 39: 119-131.
10. Rival Y, Beneteau N, Taillandier T, Pezet M, Dupont-Passelaigue E, et al. (2002) PPARalpha and PPARdelta activators inhibit cytokine-induced nuclear translocation of NF-kappaB and expression of VCAM-1 in EAhy926 endothelial cells. Eur J Pharmacol 435: 143-151.
11. Planavila A, Rodriguez-Calvo R, Jove M, Michalik L, Wahli W, et al. (2005) Peroxisome proliferator-activated receptor beta/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes. Cardiovasc Res 65: 832-841.
12. Westergaard M, Henningsen J, Johansen C, Rasmussen S, Svendsen ML, et al. (2003) Expression and localization of peroxisome proliferator-activated receptors and nuclear factor kappaB in normal and lesional psoriatic skin. J Invest Dermatol 121: 1104-1117.
13. Ding G, Cheng L, Qin Q, Frontin S, Yang Q, (2006) PPARdelta modulates lipopolysaccharide-induced TNFalpha inflammation signaling in cultured cardiomyocytes. J Mol Cell Cardiol 40: 821-828.
14. Lee CH, Chawla A, Urbiztondo N, Liao D, Boisvert WA, et al. (2003) Transcriptional repression of atherogenic inflammation: modulation by PPARdelta. Science 302: 453-457.
15. Kanakasabai S, Chearwae W, Walline CC, Iams W, Adams SM, et al. (2010) Peroxisome proliferator-activated receptor delta agonists inhibit T helper type 1 (Th1) and Th17 responses in experimental allergic encephalomyelitis. Immunology 130: 572-588.
16. Peters JM, Lee SS, Li W, Ward JM, Gavrilova O, et al. (2000) Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta). Mol Cell Biol 20: 5119-5128.
17. Chong HC, Tan MJ, Philippe V, Tan SH, Tan CK, et al. (2009) Regulation of epithelial-mesenchymal IL-1 signaling by PPARbeta/delta is essential for skin homeostasis and wound healing. J Cell Biol 184: 817-831.
18. Romanowska M, Reilly L, Palmer CN, Gustafsson MC, Foerster J, (2010) Activation of PPARbeta/delta causes a psoriasis-like skin disease in vivo. PLoS One 5: e9701.
19. Schmitz ML, Weber A, Roxlau T, Gaestel M, Kracht M, (2011) Signal integration, crosstalk mechanisms and networks in the function of inflammatory cytokines. Biochim Biophys Acta 1813: 2165-2175.
20. Dinarello CA, (2011) Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 117: 3720-3732.
21. Weber A, Wasiliew P, Kracht M, (2010) Interleukin-1 (IL-1) pathway. Sci Signal 3: cm1.
22. Schmitz ML, Mattioli I, Buss H, Kracht M, (2004) NF-kappaB: a multifaceted transcription factor regulated at several levels. Chembiochem 5: 1348-1358.
23. Perkins ND, (2012) The diverse and complex roles of NF-kappaB subunits in cancer. Nat Rev Cancer 12: 121-132.
24. Alford KA, Glennie S, Turrell BR, Rawlinson L, Saklatvala J, et al. (2007) Heat shock protein 27 functions in inflammatory gene expression and transforming growth factor-beta-activated kinase-1 (TAK1)-mediated signaling. J Biol Chem 282: 6232-6241.
25. Cao X, Yue L, Song J, Wu Q, Li N, et al. (2012) Inducible HSP70 antagonizes IL-1beta cytocidal effects through inhibiting NF-kB activation via destabilizing TAK1 in HeLa cells. PLoS One 7: e50059.
26. Chen R, Li M, Zhang Y, Zhou Q, Shu HB, (2012) The E3 ubiquitin ligase MARCH8 negatively regulates IL-1beta-induced NF-kappaB activation by targeting the IL1RAP coreceptor for ubiquitination and degradation. Proc Natl Acad Sci U S A 109: 14128-14133.
27. Ma Q, Zhou L, Shi H, Huo K, (2008) NUMBL interacts with TAB2 and inhibits TNFalpha and IL-1beta-induced NF-kappaB activation. Cell Signal 20: 1044-1051.
28. Russo MP, Bennett BL, Manning AM, Brenner DA, Jobin C, (2002) Differential requirement for NF-kappaB-inducing kinase in the induction of NF-kappaB by IL-1beta, TNF-alpha, and Fas. Am J Physiol Cell Physiol 283: C347-357.
29. Sakai A, Han J, Cato AC, Akira S, Li JD, (2004) Glucocorticoids synergize with IL-1beta to induce TLR2 expression via MAP Kinase Phosphatase-1-dependent dual Inhibition of MAPK JNK and p38 in epithelial cells. BMC Mol Biol 5: 2.
30. Yang HT, Cohen P, Rousseau S, (2008) IL-1beta-stimulated activation of ERK1/2 and p38alpha MAPK mediates the transcriptional up-regulation of IL-6, IL-8 and GRO-alpha in HeLa cells. Cell Signal 20: 375-380.
31. Parcellier A, Schmitt E, Gurbuxani S, Seigneurin-Berny D, Pance A, et al. (2003) HSP27 is a ubiquitin-binding protein involved in I-kappaBalpha proteasomal degradation. Mol Cell Biol 23: 5790-5802.
32. Park KJ, Gaynor RB, Kwak YT, (2003) Heat shock protein 27 association with the I kappa B kinase complex regulates tumor necrosis factor alpha-induced NF-kappa B activation. J Biol Chem 278: 35272-35278.
33. Wu Y, Liu J, Zhang Z, Huang H, Shen J, et al. (2009) HSP27 regulates IL-1 stimulated IKK activation through interacting with TRAF6 and affecting its ubiquitination. Cell Signal 21: 143-150.
34. Park BH, Vogelstein B, Kinzler KW, (2001) Genetic disruption of PPARdelta decreases the tumorigenicity of human colon cancer cells. Proc Natl Acad Sci U S A 98: 2598-2603.
35. Thiefes A, Wolf A, Doerrie A, Grassl GA, Matsumoto K, et al. (2006) The Yersinia enterocolitica effector YopP inhibits host cell signalling by inactivating the protein kinase TAK1 in the IL-1 signalling pathway. EMBO Rep 7: 838-844.
36. Thiefes A, Wolter S, Mushinski JF, Hoffmann E, Dittrich-Breiholz O, et al. (2005) Simultaneous blockade of NFkappaB, JNK, and p38 MAPK by a kinase-inactive mutant of the protein kinase TAK1 sensitizes cells to apoptosis and affects a distinct spectrum of tumor necrosis factor [corrected] target genes. J Biol Chem 280: 27728-27741.
37. Müller-Brüsselbach S, Kömhoff M, Rieck M, Meissner W, Kaddatz K, et al. (2007) Deregulation of tumor angiogenesis and blockade of tumor growth in PPARβ-deficient mice. Embo J 26: 3686-3698.
38. Holtmann H, Enninga J, Kalble S, Thiefes A, Dorrie A, et al. (2001) The MAPK kinase kinase TAK1 plays a central role in coupling the interleukin-1 receptor to both transcriptional and RNA-targeted mechanisms of gene regulation. J Biol Chem 276: 3508-3516.
39. Sakurai H, Miyoshi H, Mizukami J, Sugita T, (2000) Phosphorylation-dependent activation of TAK1 mitogen-activated protein kinase kinase kinase by TAB1. FEBS Lett 474: 141-145.
40. Buss H, Dorrie A, Schmitz ML, Hoffmann E, Resch K, et al. (2004) Constitutive and interleukin-1-inducible phosphorylation of p65 NF-{kappa}B at serine 536 is mediated by multiple protein kinases including I{kappa}B kinase (IKK)-{alpha}, IKK{beta}, IKK{epsilon}, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription. J Biol Chem 279: 55633-55643.
41. Rogalla T, Ehrnsperger M, Preville X, Kotlyarov A, Lutsch G, et al. (1999) Regulation of Hsp27 oligomerization, chaperone function, and protective activity against oxidative stress/tumor necrosis factor alpha by phosphorylation. J Biol Chem 274: 18947-18956.
42. Hoffmann E, Thiefes A, Buhrow D, Dittrich-Breiholz O, Schneider H, et al. (2005) MEK1-dependent delayed expression of Fos-related antigen-1 counteracts c-Fos and p65 NF-kappaB-mediated interleukin-8 transcription in response to cytokines or growth factors. J Biol Chem 280: 9706-9718.
43. Kaddatz K, Adhikary T, Finkernagel F, Meissner W, Müller-Brüsselbach S, et al. (2010) Transcriptional profiling identifies functional interactions of TGFβ and PPARβ/δ signaling: synergistic induction of ANGPTL4 transcription. J Biol Chem 285: 29469-29479.
44. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80.
45. Sznaidman ML, Haffner CD, Maloney PR, Fivush A, Chao E, et al. (2003) Novel selective small molecule agonists for peroxisome proliferator-activated receptor delta (PPARdelta)-synthesis and biological activity. Bioorg Med Chem Lett 13: 1517-1521.
46. Naruhn S, Toth PM, Adhikary T, Kaddatz K, Pape V, et al. (2011) High-affinity peroxisome proliferator-activated receptor beta/delta-specific ligands with pure antagonistic or inverse agonistic properties. Mol Pharmacol 80: 828-838.
47. Mangan S, Alon U, (2003) Structure and function of the feed-forward loop network motif. Proc Natl Acad Sci U S A 100: 11980-11985.
48. Brunet Simioni M, De Thonel A, Hammann A, Joly AL, Bossis G, et al. (2009) Heat shock protein 27 is involved in SUMO-2/3 modification of heat shock factor 1 and thereby modulates the transcription factor activity. Oncogene 28: 3332-3344.
49. Chinetti G, Griglio S, Antonucci M, Torra IP, Delerive P, et al. (1998) Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages. J Biol Chem 273: 25573-25580.
50. Sumanasekera WK, Tien ES, Turpey R, Vanden Heuvel JP, Perdew GH, (2003) Evidence that peroxisome proliferator-activated receptor alpha is complexed with the 90-kDa heat shock protein and the hepatitis virus B X-associated protein 2. J Biol Chem 278: 4467-4473.
51. Umemoto T, Fujiki Y, (2012) Ligand-dependent nucleo-cytoplasmic shuttling of peroxisome proliferator-activated receptors, PPARalpha and PPARgamma. Genes Cells 17: 576-596.
52. Bishop-Bailey D, Hla T, (1999) Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-Delta12, 14-prostaglandin J2. J Biol Chem 274: 17042-17048.
53. Takayama O, Yamamoto H, Damdinsuren B, Sugita Y, Ngan CY, et al. (2006) Expression of PPARdelta in multistage carcinogenesis of the colorectum: implications of malignant cancer morphology. Br J Cancer 95: 889-895.
54. Zhou B, Liang PF, Yang XH, Huang XY, Ren LC, (2011) [Regulation of peroxisome proliferator-activated receptor beta by epidermal growth factor in wound tissue of mice with full-thickness skin defect]. Zhonghua Shao Shang Za Zhi 27: 446-450.
55. Cristiano L, Cimini A, Moreno S, Ragnelli AM, Paola Ceru M, (2005) Peroxisome proliferator-activated receptors (PPARs) and related transcription factors in differentiating astrocyte cultures. Neuroscience 131: 577-587.
56. Smale ST, (2011) Hierarchies of NF-kappaB target-gene regulation. Nat Immunol 12: 689-694.
57. Medzhitov R, Horng T, (2009) Transcriptional control of the inflammatory response. Nat Rev Immunol 9: 692-703.
58. Moreno R, Sobotzik JM, Schultz C, Schmitz ML, (2010) Specification of the NF-kappaB transcriptional response by p65 phosphorylation and TNF-induced nuclear translocation of IKK epsilon. Nucleic Acids Res 38: 6029-6044.
59. Brunmair B, Staniek K, Dorig J, Szocs Z, Stadlbauer K, et al. (2006) Activation of PPAR-delta in isolated rat skeletal muscle switches fuel preference from glucose to fatty acids. Diabetologia 49: 2713-2722.
60. Krämer DK, Al-Khalili L, Guigas B, Leng Y, Garcia-Roves PM, et al. (2007) Role of AMP kinase and PPARdelta in the regulation of lipid and glucose metabolism in human skeletal muscle. J Biol Chem 282: 19313-19320.
61. Yang X, Kume S, Tanaka Y, Isshiki K, Araki S, et al. (2011) GW501516, a PPARdelta agonist, ameliorates tubulointerstitial inflammation in proteinuric kidney disease via inhibition of TAK1-NFkappaB pathway in mice. PLoS One 6: e25271.
62. Kostenko S, Moens U, (2009) Heat shock protein 27 phosphorylation: kinases, phosphatases, functions and pathology. Cell Mol Life Sci 66: 3289-3307.
63. Knapinska AM, Gratacos FM, Krause CD, Hernandez K, Jensen AG, et al. (2011) Chaperone Hsp27 modulates AUF1 proteolysis and AU-rich element-mediated mRNA degradation. Mol Cell Biol 31: 1419-1431.
64. Lasa M, Mahtani KR, Finch A, Brewer G, Saklatvala J, et al. (2000) Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade. Mol Cell Biol 20: 4265-4274.
65. Dempsey CE, Sakurai H, Sugita T, Guesdon F, (2000) Alternative splicing and gene structure of the transforming growth factor beta-activated kinase 1. Biochim Biophys Acta 1517: 46-52.